Literature DB >> 12463478

Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?

Norihiro Awaya1, Gabriela M Baerlocher, Thomas J Manley, Jean E Sanders, Marco Mielcarek, Beverly Torok-Storb, Peter M Lansdorp.   

Abstract

Telomeres serve to maintain the structural integrity of chromosomes, yet each somatic cell division is associated with a decrease in telomere length. The cumulative decrease in telomere length can impose an upper limit for the number of cell divisions that can occur before a cell senesces. When studied in vitro with fibroblasts, this limit is referred to as the Hayflick limit and usually occurs after 40 to 80 cell doublings. In theory, a similar replicative potential in a hematopoietic stem cell could support hematopoiesis in a person for more than 100 years. However, stem cells differentiate, and the telomere length differs among chromosomes within a single cell, among cell types, and among age-matched individuals. This variation in telomere length raises the possibility that long-term hematopoiesis by transplanted stem cells could, depending on the telomere length of the engrafted stem cell and the proliferative demand to which it is subjected, reach a Hayflick limit during the life span of the patient. Although significant shortening of telomeres is reported to occur within the first year posttransplantation, as yet no evidence has indicated that this shortening is associated with marrow function. In this review, we summarize reports on telomere shortening in stem cell transplantation recipients and report 2 cases in which graft failure is associated with significant telomere shortening.

Entities:  

Mesh:

Year:  2002        PMID: 12463478     DOI: 10.1053/bbmt.2002.v8.abbmt080597

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  12 in total

1.  Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA).

Authors:  Mark Hills; Kai Lücke; Elizabeth A Chavez; Connie J Eaves; Peter M Lansdorp
Journal:  Blood       Date:  2009-04-09       Impact factor: 22.113

Review 2.  Senescence of hematopoietic stem cells and bone marrow failure.

Authors:  Jichun Chen
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 3.  Concise review: hematopoietic stem cell aging, life span, and transplantation.

Authors:  Gary Van Zant; Ying Liang
Journal:  Stem Cells Transl Med       Date:  2012-09-05       Impact factor: 6.940

4.  Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.

Authors:  Régis Peffault de Latour; Rodrigo T Calado; Marc Busson; Jeffrey Abrams; Nadir Adoui; Marie Robin; Jérôme Larghero; Nathalie Dhedin; Alienor Xhaard; Emmanuel Clave; Dominique Charron; Antoine Toubert; Pascale Loiseau; Gérard Socié; Neal S Young
Journal:  Blood       Date:  2012-09-04       Impact factor: 22.113

5.  The long and the short of telomeres in bone marrow recipient SCID patients.

Authors:  Marcella Sarzotti-Kelsoe; Xiaoju G Daniell; John F Whitesides; Rebecca H Buckley
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 6.  Telomere biology in hematopoiesis and stem cell transplantation.

Authors:  Shahinaz M Gadalla; Sharon A Savage
Journal:  Blood Rev       Date:  2011-07-20       Impact factor: 8.250

7.  Predicting clonal self-renewal and extinction of hematopoietic stem cells.

Authors:  Hans B Sieburg; Betsy D Rezner; Christa E Muller-Sieburg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

Review 8.  Mixing old and young: enhancing rejuvenation and accelerating aging.

Authors:  Ashley Lau; Brian K Kennedy; James L Kirkland; Stefan G Tullius
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

9.  Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.

Authors:  Shahinaz M Gadalla; Carmem Sales-Bonfim; Jeanette Carreras; Blanche P Alter; Joseph H Antin; Mouhab Ayas; Prasad Bodhi; Jeffrey Davis; Stella M Davies; Eric Deconinck; H Joachim Deeg; Reggie E Duerst; Anders Fasth; Ardeshir Ghavamzadeh; Neelam Giri; Frederick D Goldman; E Anders Kolb; Robert Krance; Joanne Kurtzberg; Wing H Leung; Alok Srivastava; Reuven Or; Carol M Richman; Philip S Rosenberg; Jose Sanchez de Toledo Codina; Shalini Shenoy; Gerard Socié; Jakub Tolar; Kirsten M Williams; Mary Eapen; Sharon A Savage
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-08       Impact factor: 5.742

10.  Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure.

Authors:  Shahinaz M Gadalla; Geraldine Aubert; Tao Wang; Michael Haagenson; Stephen R Spellman; Lingxiao Wang; Hormuzd A Katki; Sharon A Savage; Stephanie J Lee
Journal:  Blood       Date:  2018-04-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.